BiotechTube
Home/Myosin Therapeutics/Karen Smith
KS

Karen Smith

Chief Medical Officer

Myosin Therapeutics

Roles

Chief Medical OfficeratMyosin Therapeutics
Director & Interim CMOatAummune

Therapeutic Areas

OncologyNeuroscienceMusculoskeletal

Myosin Therapeutics Pipeline

DrugIndicationPhase
MT-125Glioblastoma (GBM), MGMT unmethylatedPhase 1/2
MT-228Oncology (likely PDAC)Preclinical
MT-110Substance Use Disorder (SUD)Preclinical
MT-134MusculoskeletalPreclinical

Leadership Team at Myosin Therapeutics

CA
Courtney A. Miller
Chief Executive Officer
PR
Patrick R. Griffin
Chief Scientific Officer
TK
Theodore Kamenecka
Chief Scientific Officer
View full Myosin Therapeutics profile